Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Reset all filters
01 1Biophore India Pharmaceuticals Private Limited
02 1Enaltec Labs Pvt Ltd
03 1Assia Chemical Industries Ltd - Teva Tech Site
04 1Aurobindo Pharma Limited
05 1Cutyx Research LLP
06 1MSN Laboratories Private Limited
07 3Zhejiang Ausun Pharmaceutical Co., Ltd.
Reset all filters
01 9Ramelteon
Reset all filters
01 3China
02 4India
03 1Israel
04 1Blank
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
NDC Package Code : 73435-003
Start Marketing Date : 2019-12-09
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42413-0180
Start Marketing Date : 2019-05-10
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63415-0150
Start Marketing Date : 2017-11-27
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 59651-469
Start Marketing Date : 2024-01-11
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 14501-0030
Start Marketing Date : 2017-03-29
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 76397-021
Start Marketing Date : 2020-01-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 76397-032
Start Marketing Date : 2022-09-15
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT

NDC Package Code : 76397-050
Start Marketing Date : 2025-11-27
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT

NDC Package Code : 85411-120
Start Marketing Date : 2025-06-01
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
58
PharmaCompass offers a list of Ramelteon API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Ramelteon manufacturer or Ramelteon supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ramelteon manufacturer or Ramelteon supplier.
A Ramelteon manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ramelteon, including repackagers and relabelers. The FDA regulates Ramelteon manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ramelteon API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ramelteon manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Ramelteon supplier is an individual or a company that provides Ramelteon active pharmaceutical ingredient (API) or Ramelteon finished formulations upon request. The Ramelteon suppliers may include Ramelteon API manufacturers, exporters, distributors and traders.
click here to find a list of Ramelteon suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ramelteon as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ramelteon API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ramelteon as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ramelteon and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ramelteon NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ramelteon suppliers with NDC on PharmaCompass.
We have 6 companies offering Ramelteon
Get in contact with the supplier of your choice: